Estudio de Belzutifan en combinación con lenvatinib frente a cabozantinib para el tratamiento del carcinoma de células renales
This study will compare the efficacy and safety of belzutifan + lenvatinib versus cabozantinib in participants with advanced renal cell carcinoma (RCC) with clear cell component after prior therapy. The primary